Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PTH bioactivity in osteoporosis.

P W Saphier1, T C Stamp, C R Kelsey

  • 1Kennedy Institute of Rheumatology, London, England.

Bone and Mineral
|October 1, 1987
PubMed
Summary

Parathyroid hormone (PTH) bioactivity levels in osteoporotic patients revealed distinct groups, with elevated levels correlating to fewer fractures. This study highlights the importance of measuring bioactive PTH in osteoporosis research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study.

Bone marrow transplantation·2014
Same author

The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility.

Calcified tissue international·2009
Same author

Effects of physical activity on evolution of proximal femur structure in a younger elderly population.

Bone·2006
Same author

Sex hormone status may modulate rate of expansion of proximal femur diameter in older women alongside other skeletal regulators.

The Journal of clinical endocrinology and metabolism·2006
Same author

Clusters and composites: Bone turnover and femoral neck fragility.

Journal of musculoskeletal & neuronal interactions·2005

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Gerontology

Background:

  • Osteoporosis is a significant health concern in the elderly, characterized by low bone mass and increased fracture risk.
  • Parathyroid hormone (PTH) plays a crucial role in calcium and bone homeostasis.
  • Understanding PTH levels in aging and osteoporosis is vital for developing effective treatments.

Purpose of the Study:

  • To measure parathyroid hormone (PTH) bioactivity in normal elderly individuals and patients with osteoporosis.
  • To investigate the relationship between PTH levels, age, and fracture incidence in osteoporotic populations.
  • To compare bioavailable PTH with immunoreactive PTH in distinguishing osteoporotic patient groups.

Main Methods:

  • Utilized a cytochemical bioassay to quantify PTH bioactivity in plasma samples.
  • Assessed PTH bioactivity in normal elderly subjects and patients with idiopathic or postmenopausal osteoporosis.
  • Measured immunoreactive PTH levels and analyzed fracture history.

Main Results:

  • PTH bioactivity did not increase with age in normal elderly subjects.
  • Osteoporotic patients were categorized into two groups based on PTH bioactivity: normal and elevated levels.
  • Patients with high bio- and immunoreactive PTH levels exhibited a lower incidence of recent fractures.

Conclusions:

  • Bioactive PTH levels can differentiate between osteoporotic patient subgroups.
  • Elevated bioactive PTH may be associated with a reduced risk of fractures in osteoporotic individuals.
  • Further research is warranted to explore the therapeutic implications of these findings.

Related Experiment Videos